GT Medical Technologies, a company committed to improving outcomes for patients with brain tumors, has announced that Dartmouth Cancer Center has been designated as a GammaTile Center of Excellence. This recognition highlights institutions and physicians who demonstrate outstanding expertise in the GammaTile procedure and maintain high standards in patient care, clinical experience, and continuing education. The physicians recognized for this achievement include Dr. Linton Evans and Dr. Nathan Simmons in Neurosurgery, Dr. Greg Russo in Radiation Oncology, and Drs. Nupur Lala and Tulika Ranjan in Neuro-Oncology.

Health Technology Insights: Novotech White Paper Boosts Early-Phase Oncology Strategy

GammaTile is an advanced form of radiation therapy applied during tumor removal surgery. It delivers targeted radiation directly to the tumor site immediately after surgery, when remaining cancer cells are at their lowest levels.

Health Technology Insights: Spruce Biosciences Appoints Keli Walbert to Board

Unlike conventional radiation therapy, which often begins weeks after surgery to allow for wound healing, GammaTile eliminates this delay, aiming to enhance the effectiveness of treatment and lower the risk of tumor recurrence. This approach provides a timely, localized, and continuous radiation dose designed to improve patient outcomes and support comprehensive brain tumor care.

Health Technology Insights: Matrix One Acquires dokspot to Launch Matrix eIFU

To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com